Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06909006 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Semaglutide Treatment in Type 1 Diabetes

Study acronym: OBES1TY
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv3
  2. Eligibility criteria expanded, about 15 words
    • Secondary endpoints: 40 to 42
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Nordsjaellands Hospital
27 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
Type 1 Diabetes
886 trials monitored
See 40 trials at risk
The goal of this clinical trial is to investigate the efficacy of semaglutide on body weight, insulin dose requirements and improvements in glucose control and safety aspects in regards to risk of hypoglycemia and diabetic ketoacidosis for patients with established Type 1 Diabetes.
Trial Details
NCT Number NCT06909006
Lead Sponsor Nordsjaellands Hospital
Collaborators: Steno Diabetes Center Copenhagen, Steno Diabetes Center Odense, Zealand University Hospital, Aarhus University Hospital
Conditions
(from sponsor)		 Obesity in Diabetes, Obesity/Therapy, Type 1 Diabetes Mellitus (T1DM), Insulin Sensitivity/Resistance, Semaglutide, Lipidomics, Metabolomics, Weight Loss +1 more
Related terms Diabetes Mellitus, Type 1, Insulin Resistance, Obesity, Weight Loss
Enrollment 122 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov